Report Categories
View AllRecent Articles
View All
Zen Technologies Surges Over 7 on Smart Border Suite Launch
Google Pixel Launch Sparks Privacy Concerns Over AI Assistant Data Practices
Micron CEO Sanjay Mehrotra Reaches Billionaire Status Amid Memory Chip Sector Surge
Endurance Technologies IPO Opens Key Details and Market Context
Canaccord Lowers Regeneron Price Target After Disappointing Phase 3 Trial Outcome
Cable One CABO Q1 2026 Earnings Earnings Beat Estimates Stock Surges 965
Seabridge Gold SA Q1 2024 Earnings DevelopmentStage Miner Posts Net Loss No Revenue as KSM Project Advances
FMAO Q1 2026 Earnings EPS Surpasses Estimates Amidst Challenging Interest Rate Environment
ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending
SVCO Q1 2026 Earnings EPS Surprises to the Upside Despite Narrower Loss Stock Rises
Somnigroup International SGI Edges Lower Amid Quiet Trading Key Levels in Focus
Liberty AllStar Equity Fund Edges Higher Amid Steady Trading
Sera Prognostics Surges 15 Bullish Momentum Meets Key Resistance at 217
Phibro Animal Health PAHC Holds Near Support Amid Modest Pullback
Brent and WTI Crude Prices Diverge as Market Focus Shifts
Oil Prices Drop Over 5 Amid Hopes of Iran Nuclear Deal
DeepSeek Announces Permanent 75 Price Reduction on Flagship V4Pro AI Model
Enhanced Games Secures Backing from Donald Trump Jr Prepares for Inaugural Event and Product Expansion
External Links
Consumer Price Index Rises 38 in April Marking Highest Annual Gain Since May 2023
SPT Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Unavailable
MTB Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher
GILD Q1 2026 Earnings EPS Surpasses Estimates Shares Rally 296
UCB Q1 2026 Earnings EPS Slightly Misses Estimates Amid Positive Market Reaction
Grindr Inc Q4 2025 Earnings EPS Misses Estimates Despite Positive User Trends
Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues
22nd Century Group Q1 2026 Earnings Massive EPS Miss Sparks Investor Concern
DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist
OCFC Q1 2026 Earnings EPS Beat of 591 Highlights Resilience Amid Slight Stock Decline